[Treatment of herpes infections with transfer factor].
Twelve patients suffering from recurrent herpetic infections resistant to several current therapies were treated for a 3 to 10 months period with a bovine transfer factor specific to Herpes simplex virus of type 1 and 2. The results obtained showed that this treatment was capable of dramatically reducing the intensity, duration and frequency of the relapses. This preliminary clinical trial suggests that specific transfer factor administered orally could be an effective treatment of herpes infections.
D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000032:analysis; D002464:Cell Migration Inhibition; D002986:Clinical Trials as Topic; D005260:Female; D005500:Follow-Up Studies; D006561:Herpes Simplex / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007962:Leukocytes / Q000276:immunology; D008297:Male; D008875:Middle Aged; D014165:Transfer Factor / Q000627:therapeutic use*
D000914:Antibodies, Viral; D014165:Transfer Factor
Traitement des infections herpétiques par le facteur de transfert.